May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
The Role of NF– B p65 in TNF––Induced Optic Nerve Degeneration
Author Affiliations & Notes
  • Y. Kitaoka
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
    Ophthalmology, St. Marianna University School of Medicine, Kawasaki–shi, Kanagawa, Japan
  • Y. Kitaoka
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
    Ophthalmology, St. Marianna University School of Medicine, Kawasaki–shi, Kanagawa, Japan
  • F.N. Ross–Cisneros
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
  • A.A. Sadun
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
  • T.T. Lam
    Ophthalmology, Doheny Eye Institute/USC, Los Angeles, CA
  • Footnotes
    Commercial Relationships  Y. Kitaoka, None; Y. Kitaoka, None; F.N. Ross–Cisneros, None; A.A. Sadun, None; T.T. Lam, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1196. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Kitaoka, Y. Kitaoka, F.N. Ross–Cisneros, A.A. Sadun, T.T. Lam; The Role of NF– B p65 in TNF––Induced Optic Nerve Degeneration . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1196.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We previously showed an increased expression of NF–Κ B p65 in TNF–α–induced optic nerve degeneration. The purpose of this study was to examine its role in the degenerative process. Methods: Rats were euthanized at 1 day, 1, 2 weeks, 1 or 2 months after TNF–α (1–10 ng) intravitreal injection. Morphometric analysis of cells in the retinal ganglion cell layer (RGCL) and axon counting in optic nerve were performed. Immunohistochemistry was performed with antibodies against NF–Κ B p65, TNF–receptor 1 (R1), TNF–receptor 2 (R2), ED–1 or neurofilament. Results: Morphometry of cells in the RGCL showed a delayed loss (only significant at 2 months) as compared to the loss of axons in the optic nerve, which showed significant loss in 2 weeks. NF–Κ B p65 immunoreactivity was colocalized with TNF–R1, TNF–R2 or ED–1, a marker of microglia/phagocytic cells, in the optic nerve. Inhibition of NF–Κ B p65 with antisense oligodeoxynucleotide or helenalin, an inhibitor of NF–Κ B p65 binding to DNA, significantly ameliorated the loss of axon number after TNF–α injection. Conclusions: Intravitreal TNF–α caused axonal degeneration with delayed loss of retinal cell bodies. TNF–R1 and TNF–R2 may be involved in NF–Κ B p65 activation. Microglial cells with upregulation of NF–Κ B p65 may contribute to TNF–α–induced axonal degeneration of optic nerve.

Keywords: neuro-ophthalmology: optic nerve • neuroprotection • immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×